TX-MARY-KAY
30.12.2019 18:13:04 CET | Business Wire | Press release
In 2019, Mary Kay Inc. continued its decades-long commitment to enriching the lives of women around the globe, manufacturing irresistible products and building healthier, more sustainable communities. In recognition of Mary Kay’s achievements throughout the year, the brand has taken home more than 20 coveted awards in the business, corporate citizenship and leadership categories from various reputable sources.
The awards, which range from Forbes “Best Midsize Employers for 2019” to “Best in Show” at Boston College Center for Corporate Citizenship Film Festival, highlight Mary Kay’s unwavering business values and its dedication to the principles defined by the brand’s legendary founder, Mary Kay Ash.
Awards in 2019 include:
Excellence in Business
- Best Employers for Diversity, 2019 – Forbes
- Best Midsize Employer, 2019 – Forbes
- Gold Ranking in Educational Category – Spring 2019 OMNI Awards
- Top 50 U.S.-based Companies in Household and Personal Products Industry – HAPPI Magazine
- DSA Empowerment Award, 2019 – Direct Selling Association
- Most Reputable Global Employers in 2019 Global Workplace 100 Study – Reputation Institute
- 2019 Compliance Award – EXPANSION
- Top Brand, 2019 – VIP Magazine
- Women Entrepreneurship Award - Woman Who Matters Forum
- Best Magazine for Clients, Mary Kay Russia Applause® – Media Leader
- Best Client Media: Web Media, Mary Kay Russia MirrorMe™ App – Corporate Media Awards
Excellence in Corporate Citizenship
- Fan Favorite, video: Mary Kay’s Commitment to Ending Domestic Violence – Boston College Center for Corporate Citizenship International Corporate Citizenship Film Festival
- Best in Show – Small Company Category, video: Mary Kay’s Commitment to Ending Domestic Violence – Boston College Center for Corporate Citizenship International Corporate Citizenship Film Festival
- 2019 Leadership in Energy and Environmental Design (LEED) Silver Certification – Mary Kay Richard R. Rogers Manufacturing and R&D Center
- Best CSR Brand and Best CSR Strategy Award, Mary Kay China – CSR China Education Awards
Excellence in Leadership
- 10 Most Reputable CEOS in the World, David Hall, Mary Kay CEO, RepTrak 2019 Study – Reputation Institute
- 2019 Most Powerful Women in Corporate America, Sheryl Adkins-Green, Chief Marketing Officer – BLACK ENTERPRISE Magazine
- 2019 Most Powerful Women in Corporate America, Julia Simon, Chief Legal Officer and Corporate Secretary – BLACK ENTERPRISE Magazine
- 500 Most Influential Women in Spain, Gema Aznar, Mary Kay Spain General Manager – Yo Dona Magazine
- Most Powerful Female Business Leaders, Claudia Maria Cardona, Marketing Manager, Mary Kay Colombia – ALO Magazine
- Manager of the Year, Alla Sokolova, Mary Kay Russia General Manager – Russian Business Guide
- Top 250 Best Top Managers, Alla Sokolova, Mary Kay Russia General Manager – The Association Managers of Russia and Kommersant Publishing House
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 56 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20191230005280/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom